129
Views
1
CrossRef citations to date
0
Altmetric
Articles

Nanoscale synthesis, structural elucidation, DFT, and biological activity of amide appended transition metal(II) macrocyclic complexes in drug delivery system

, , , , &
Pages 2843-2857 | Received 23 Aug 2022, Accepted 10 Nov 2022, Published online: 03 Jan 2023
 

Abstract

Nanoscale complexes of Mn(II), Ni(II), and Cu(II) with 6,15-diamino-1,4,9,12-tetraazacyclohexadecane-5,8,13,16-tetraone were synthesized by ultrasonic sonication method. The Fourier-transform infrared (FTIR) spectroscopy, ultraviolet–visible (UV–vis) spectroscopy, carbon, hydrogen, and nitrogen elemental (CHN) analysis, mass spectrometry (MS), and electron spin resonance (ESR) spectroscopy were used to identify and suggest the structure of the synthesized nanocomplexes. The field emission scanning electron microscopy (FE-SEM) and powder X-ray diffraction (PXRD) revealed that the size of the synthesized nanocomplexes was 44–58 nm. Based on these studies, hexagonal, monoclinic, and cubic unit cell structure has been proposed for the synthesized Mn(II), Ni(II), and Cu(II), respectively. The theoretical calculations of the synthesized nanocomplexes were carried out by a GAUSSIAN 09 program involving geometry optimization and bond parameters using the B3LYP method. Moreover, binding energy, HOMO, and LUMO have been calculated. In addition, hardness, softness, chemical potential, and dipole moment were calculated for ligand and its metal nanocomplexes. The biological efficacy of the synthesized nanocomplexes was examined and found to be better and highly effective drug delivery system (DDS) for the antimicrobial and antioxidative agent.

Acknowledgment

The authors are grateful to authorities of TIET, Patiala, for providing necessary research facilities.

Disclosure statement

The authors have no conflicts to declare.

Additional information

Funding

The authors are grateful to Council of Scientific & Industrial Research, New Delhi, for financial help in the form junior research fellowship (file no. 09/140(0180)/2020-EMR-I).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.